Noninvasive Tests for NASH
Hear Stephen A. Harrison, MD, COL (Ret.), FAASLD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests in NASH, including their use in:• Diagnosis of NASH patients with NAS ≥ 4 and fibrosis ≥ F2• Assessment of therapeutic response• Assessment of long-term patient outcomes Download the slides from this podcast at:https://bit.ly/3il5rqG See more NASH topics at: https://bit.ly/3ezkBq6